TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate.

Journal: Cell

Published: 2020-07-02

DOI: 10.1016/j.cell.2020.05.049

Affiliations: 17

Authors: 26

Go to article
Institutions Share
Division of Hematology and Medical Oncology, Cornell University, United States of America (USA) 0.37
Centre for Lymphoid Cancer (CLC), BCCA, Canada 0.15
Princess Margaret Cancer Centre, U of T, Canada 0.06
Terry Fox Laboratory, Canada 0.06
Immunology and Microbial Pathogenesis Program (IMP), Cornell University, United States of America (USA) 0.05
Immunology Program, MSKCC, United States of America (USA) 0.05
Department of Biochemistry, U of T, Canada 0.04
Department of Pathology and Laboratory Medicine, Cornell University, United States of America (USA) 0.04
NIH NCI Cancer Genomics Research Laboratory (CGR), United States of America (USA) 0.04
Caryl and Israel Englander Institute for Precision Medicine (IPM), Cornell University, United States of America (USA) 0.04
Tri-Institutional PhD Program in Computational Biology and Medicine (CBM), United States of America (USA) 0.02
Department of Lymphoma and Myeloma, MD Anderson Cancer Center, United States of America (USA) 0.02
Department of Genomic Medicine, MD Anderson Cancer Center, United States of America (USA) 0.02
BC Cancer Agency (BCCA), PHSA, Canada 0.02
Louis V. Gerstner Jr. Sloan Kettering Graduate School of Biomedical Sciences, MSKCC, United States of America (USA) 0.01
Department of Medical Biophysics, U of T, Canada 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER